Inställningar

Split view

Short keys for navigating in split view

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Dark Mode

Set dark mode to MFN.se

Sound

Plays a notification sound when new press release is published in the current feed

Intresserad av platformen MFN för nyhetsdistribution?

Onsdag 28 Oktober | 21:00:25 Europe / Stockholm

Svenska | English

Bifogade filer

Prenumeration

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

XVIVO Perfusion – Consensus estimates Q3 2026

2026-10-19 14:00:00

Estimates compiled by Modular Finance on behalf of XVIVO Perfusion.

Number of contributors: 7 (all of which have been updated or confirmed before the report)

KPI (MSEK, unless otherwise specified)	Q3 2026E
Net sales	238
Organic growth in local currency (%)	25.03
Gross profit	171
EBITDA	45.8
EBIT	22.9
Net profit	17.2
Earnings per share (SEK)	0.54

XVIVO Perfusion’s Q3 report will be released on Thursday 22 October at 07.30 CEST.